@inbook{ff1964a6ddcd4c7cbd615c88dd459c56,
title = "Heart Failure",
abstract = "Older patients are the fastest growing and the most heterogeneous population. As many diseases occur more frequently with advancing age, so do cardiovascular diseases as well, and “cardiogeriatrics” has become an established term/specialty. Heart failure (HF) specifically is a highly prevalent disease in the older population. Most established standard treatments are effective in this group. However, the presence of comorbidities, polypharmacy, and frailty makes the management of HF in older patients more complex, and the benefit-risk of each treatment must be carefully weighed by a multidisciplinary team and shared with the patient and/or his/her relatives as part of a shared decision-making and a personalised care plan. We should keep in mind that we treat people, not diseases.",
keywords = "Adverse drug events, Benefit-risk, Cardiogeriatrics, Cardiovascular diseases (CVD), Comorbidities, Comprehensive geriatric assessment, Frailty, Heart failure (HF), Heart failure with mildly reduced or midrange ejection fraction (HFmrEF), Heart failure with preserved ejection fraction (HFpEF), Heart failure with reduced ejection fraction (HFrEF), Multidisciplinary, New York Heart Association (NYHA) class, Older persons, Personalised care, Polypharmacy, Underprescription",
author = "{De Backer}, {T. L.} and Mangoni, {A. A.}",
year = "2023",
doi = "10.1007/978-3-031-28061-0_19",
language = "English",
isbn = "978-3-031-28060-3",
series = "Practical Issues in Geriatrics",
publisher = "Springer Nature",
pages = "239--267",
editor = "Antonio Cherubini and Mangoni, {Arduino A.} and Denis O{\textquoteright}Mahony and Mirko Petrovic",
booktitle = "Optimizing Pharmacotherapy in Older Patients",
address = "Germany",
}